Defining nonalcoholic fatty liver disease: Implications for epidemiologic studies

Gastroenterology

Volumn 124, Issue 1, 2003, Pages 248-250

  Clark, Jeanne M ^a   Diehl, Anna Mae ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; C PEPTIDE; LEPTIN; TRIACYLGLYCEROL;

ALCOHOL CONSUMPTION; DIABETES MELLITUS; DIAGNOSTIC TEST; EDITORIAL; ETHNOLOGY; FATTY LIVER; GENDER; GLUCOSE METABOLISM; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; INSULIN RESISTANCE; LIVER DISEASE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES;

EID: 0037223610     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2003.50032     Document Type: Editorial

References (23)

1. Deaths and hospitalizations from chronic liver disease and cirrhosis-United States, 1980-1989. MMWR Weekly 1993;41:969-973.
2. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500.
3. Brunt EM. Nonalcoholic steatohepatitis: Definition and pathology. Semin Liver Dis 2001;21:3-16.
4. Datz C, Cramp M, Haas T, Dietze O, Nitschko H, Froesner G, Muss N, Sandhofer F, Vogel W. The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre. Gut 1999;44:563-567.
5. Marcellin P, Martinot M, Boyer N, Levy S. Treatment of hepatitis C patients with normal aminotransferases levels. Clin Liver Dis 1999;3:843-853.
6. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003;124;71-79.
7. Daniel S, Ben Menachem T, Vasudevan G, Ma CK, Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999;94:3010-3014.
8. Hultcrantz R, Glaumann H, Lindberg G, Nilsson LH. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 1986;21:109-113.
9. Skelly MM, James PD, Ryder SD. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol 2001;35:195-199.
10. Prati D, Taioli E, Zanella A, Della TE, Butelli S, Del Vecchio E, Vianello L, Zanuso F, Mozzi F, Milani S, Conte D, Colombo M, Sirchia G. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002;137:1-10.
11. National Center for Health Statistics. Reference Manuals and Reports: Manual for Medical Technicians and Laboratory Procedures Used for NHANES III (CD-ROM). 1996. Hyattsville, MD, Centers for Disease Control and Prevention.
12. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med 1988;27:142-149.
13. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, Cristianini G. Prevalence of chronic liver disease in the general population of northern Italy: The Dionysos Study. Hepatology 1994;20:1442-1449.
14. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-1362.
15. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Khalil L, Turpin G, Opolon P, Poynard T. Liver fibrosis in overweight patients. Gastroenterology 2000;118:1117-1123.
16. Viral Hepatitis. Department of Health and Human Services, Center for Disease Control and Prevention National Center for Health Statistics. Accessed November 7, 2002. http://www.cdc.gov/nchs/data/nhanes/databriefs/viralhep.pdf
17. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, Rizzetto M. Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-140.
18. Ong JP, Younossi ZM. Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis? Gastroenterology 2002;123:375-378.
19. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.
20. Anguio P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
21. Talwalker JA, Donlinger JJ, Gossard AA, Lindor KD. Health state preferences among patients with nonalcoholic steatohepatitis (abstr). Hepatology 2002;36:A876.
22. Cortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC. Non-alcoholic fatty liver: Another feature of the metabolic syndrome? Clin Nutr 1999;18:353-358.
23. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001;50:1844-1850.